Ignite Creation Date:
2025-12-24 @ 11:31 PM
Ignite Modification Date:
2026-01-01 @ 11:03 PM
Study NCT ID:
NCT07180056
Status:
RECRUITING
Last Update Posted:
2025-11-19
First Post:
2025-09-11
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Adjuvant CDK4/6 Inhibitor Use in HR+/HER2- Breast Cancer
Sponsor:
Wenjin Yin
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
LY2025-108-B
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None